Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Y90 ibritumomab, rx (OTHER 01643) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 10, 2026 , from http://ppman.hank.ai/transparency/procedure/01643/by-state?code_type=OTHER
“Y90 ibritumomab, rx (OTHER 01643) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/01643/by-state?code_type=OTHER. Accessed
November 10, 2026 .
“Y90 ibritumomab, rx (OTHER 01643) by State,” HANK Price Transparency ,
accessed November 10, 2026 ,
http://ppman.hank.ai/transparency/procedure/01643/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
01643 — Y90 Ibritumomab, Rx
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$56,825
National median
$55,120 – $63,512
IQR (p25 – p75)
135
hospitals filing
17
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 01643 (OTHER), with interquartile range
State Median p25 p75
CO $111,376 $111,376 $111,376
KS $65,477 $65,477 $65,477
UT $65,477 $65,477 $65,477
FL $63,512 $55,120 $63,512
IN $63,512 $63,512 $63,512
CA $62,203 $56,825 $65,477
NV $56,825 $56,825 $56,825
TX $56,825 $56,825 $56,825
MO $56,825 $56,825 $56,825
KY $55,688 $55,404 $59,928
NH $55,688 $55,120 $56,825
VA $55,655 $51,142 $58,929
LA $55,120 $55,120 $55,120
SC $55,120 $55,120 $63,512
GA $55,120 $55,120 $59,316
WY $34,746 $34,746 $34,746
AL $30,842 $30,842 $30,842